Coronaviral ion channels as target for Chinese herbal medicine

Forum on Immunopathological Diseases and Therapeutics

Volumn 3, Issue 1, 2012, Pages 1-13

  Schwarz, Silvia ^a   Sauter, Daniel ^a,c   Lü, Wei ^b   Wang, Kai ^d   Sun, Bing ^d   Efferth, Thomas ^e   Schwarz, Wolfgang ^a,b,c  

^a Shanghai Research Center for Acupuncture and Meridians   (China)

^b MAX PLANCK INSTITUTE OF BIOPHYSICS   (Germany)

^c GOETHE UNIVERSITY   (Germany)

^d INSTITUTE PASTEUR OF SHANGHAI   (China)

^e JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

Anthraquinone; Artesunate; Coronavirus; Flavanon; Flavonol; Ion channel; Isoflavon; Virus release

Indexed keywords

ANGIOTENSIN CONVERTING ENZYME 2; ARTESUNATE; BARIUM ION; EMODIN; FLAVONOL; GENISTEIN; ION CHANNEL; ISOFLAVONE; JUGLANIN; KAEMPFEROL; KAEMPFEROL 3 RHAMNOSIDE; NARINGENIN; QUERCETIN; TILIROSIDE; UNCLASSIFIED DRUG; VIRUS PROTEIN; VITRONECTIN;

ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CELL MEMBRANE POTENTIAL; CHANNEL GATING; CHINESE MEDICINE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG TARGETING; INHIBITION KINETICS; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN EXPRESSION; SARS CORONAVIRUS; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS INHIBITION; VIRUS VIRULENCE;

ARTESUNATE; CORONAVIRUS; SARS CORONAVIRUS;

EID: 84865476301     PISSN: 21518017     EISSN: 21518025     Source Type: Journal    
DOI: 10.1615/ForumImmunDisTher.2012004378     Document Type: Article

References (52)

1. Stadler K, Masignani V, Eickmann M, Becker S, Abrignani S, Klenk H-D, Rappuoli R. SARS - beginning to understand a new virus. Nature Rev. 2003;1:209-18.
2. Naithani R, Huma LC, Holland LE, Shukla D, McCormick DL, Mehta RG, Moriarty RM. Antiviral activity of phytochemicals: a comprehensive review. Mini-Rev Med Chem. 2008;8:1106-33.
3. Fischer WB, Thiel G, Fink RHA. Viral membrane proteins. Eur Biophys J. 2010;39:1041-2.
4. Krüger J, Fischer WB. Assembly of viral membrane proteins. J Chem Theory Comput. 2009;5:2503-13.
5. Wang K, Xie SSB. Viral proteins function as ion channels. Biochim Biophys Acta. 2011;1808:510-5.
6. Liang X, Li ZY. Ion channels as antivirus targets. Virologica Sinica. 2010;25:267-80.
7. Kelly ML, Cook J-A, Brown-Augsburger P, Heinz BA, Smith MC, Pinto LH. Demonstrating the intrinsic ion channel activity of virally encoded proteins. FEBS Lett. 2003;552:61-7. (Pubitemid 37103010)
8. Montal M. Structure-function correlates of Vpu, a membrane protein of HIV-1. FEBS Lett. 2003;552:47-53. (Pubitemid 37103008)
9. Lu W, Zheng BJ, Xu K, Schwarz W, Du LY, Wong CKL, Chen JD, Duan SM, Deubel V, Sun B. Severe acute respiratory syndrome-associated coronavirus 3a protein forms an ion channel and modulates virus release. Proc Natl Acad Sci. 2006;103:12540-5. (Pubitemid 44267294)
10. Zhang MM, Liu XM, He L. Effect of integrated traditional Chinese and Western medicine on SARS: a review of clinical evidence. World J Gastroenterol. 2004;10:3500-5. (Pubitemid 39555459)
11. Liu XM, Zhang MM, He L, Li YP. Chinese herbs combined with Western medicine for severe acute respiratory syndrome (SARS). Cochrane Database System. Rev. 2010, 2006, Art. No.: CD004882. DOI: 10.1002/14651858.CD004882.pub2
12. Ho TW, Wu SL, Chen JC, Li CC, Hsiang CY. Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction. Antivir Res. 2007;74:92-101.
13. Kuhn JH, Li W, Choe H, Farzan M. Antiotensin-converting enzyme 2: a functional receptor for SARS coronavirus. Cell Mol Life Sci. 2004;61:2738-43. (Pubitemid 40022435)
14. Li W, Moore JM, Vasilleva N, Sul J, Wong KS, Berne MA, Somasundaran M, Sullivan JL, Luzurlaga K, Greenough T, Choe H, Farzan M. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature. 2003;426:450-4. (Pubitemid 37490132)
15. Schwarz S, Wang K, Yu W, Sun B, Schwarz W. Emodin inhibits current through SARS-associated coronavirus 3a protein. Antivir Res. 2011;90:64-9.
16. Tan W, Lu J, Huang M, Li Y, Chen M, Wu G, Gong J, Zhong Z, Xu Z, Dang Y, Guo J, Chen X, Wang Y. Anti-cancer natural products isolated from Chinese medicinal herbs. Chinese Medicine. 2011;6(1):27. DOI:10.1186/1749-8546-6-27
17. Lown JW. Anthracycline and anthraquinone anticancer agents: current status and recent developments. Pharmacol. Ther. 1993;60:185-214. (Pubitemid 24117375)
18. Reed LJ, Muench H. A simple method of estimating fifty percent endpoints. AM J Epidemol. 1938;27:493-7.
19. Zeng R, Yang RF, Shi MD, Jiang MR, Xie YH, Ruan HQ, Jiang XS, Shi L, Zhou H, Zhang L, Wu XD, Lin Y, Ji YY, Dai EH, Wang XY, Si BY, Wang J, Wang HX. Characterisation of the 3a protein of SARS-associated coronavirus in infected vero E6 cells and SARS patients. J Mol Biol. 2004;341:271-9. (Pubitemid 39090650)
20. Lyu S-Y, Rhim J-Y, Park W-B. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (SV-2) in vitro. Arch Pharm Res. 2005;1293-301. (Pubitemid 41781926)
21. Chen L, Li J, Luo C, Liu H, Xu W, Chen G, Liew OW, Zhu W, Push CM, Shen X, Jiang H. Binding interaction of quercetin-3-+|-galactoside and its synthetic derivatives with SARS-CoV 3CLpro: Structure G Çôactivity relationship studies reveal salient pharmacophore features. Bioorg Med Chem. 2006;14:8295-306. (Pubitemid 44667555)
22. Lyu SY, Rhim JY, Park WB. Antiherpetic activities of flavonoids against herpes simplex virus type 1 (HSV-1) and type 2 (HSV-2) in vitro. Arch Pharm Res. 2005;28:1293-301.
23. Liu AL, Wang HD, Lee SMY, Wang YT, Du GH. Structure-activity relationship of flavonoids as influenza virus neuraminidase inhibitors and their in vitro anti-viral activities. Bioorg Med Chem. 2008;16:7141-7.
24. Evers DL, Chao CF, Wang X, Zhang Z, Huong SM, Huang ES. Human cytomegalovirus-inhibitory flavonoids: studies on antiviral activity and mechanism of action. Antiviral Research. 2005;68:124-34. (Pubitemid 41612456)
25. Efferth T, Dunstan H, Sauerbrey A, Miyachi H, Chitambar CR. The anti-malarial artesunate is also active against cancer. Int J Oncol. 2001;18:767-73.
26. Efferth T, Romero MR, Wolf DG, Stamminger T, Marin JJG, Marschall M. The antiviral activities of artemisinin and artesunate. Clin Infect Dis. 2008;47:804-11.
27. Lu W, Xu K, Sun B. SARS Accessory pProteins ORF3a and 9b and their functional analysis. In molecular biology of the SARScoronavirus. In: Lal SK, editor. Heidelberg: Springer Berlin. 2010, pp. 167-75.
28. Zhou Y, Frey TK, Yang JJ. Viral calciomics: Interplays between Ca2+ and virus. CellCalcium. 2009;46:1-17.
29. Xiong HR, Luo J, Hou W, Xiao H, Yang ZQ. The effect of emodin, an anthraquinone derivative extracted from the roots of Rheum tanguticum, against herpes simplex virus in vitro and in vivo. J Ethnopharmacol. 2011;133:718-23.
30. Lin CW, Wu CF, Hsiao NW, Chang CY, Li SW, Wan L, Lin YJ, Lin WY. Aloe-emodin is an interferon-inducing agent with antiviral activity against Japanese encephalitis virus and enterovirus 71. Int J Antimicrob Agents. 2008;32:355-9.
31. Hsiang CY, Ho TY. Emodin is a novel alkaline nuclease inhibitor that suppresses herpes simplex virus type 1 yields in cell cultures. Brit J Pharmacol. 2008;155:227-35.
32. Mitrocotsa D, Mitaku S, Axarlis S, Harvala C, Malamas M. Evaluation of the antiviral activity of kaempferol and its glycosides against human cytomegalovirus. Planta Med. 2000;66:377-9. (Pubitemid 30346309)
33. Chen D, Dou QP. Tea polyphenols and their roles in cancer prevention and chemotherapy. Int J Mol Sci. 2008;9:1196-206.
34. Calderon-Montano JM, Burgos-Moron E, Perez-Guerrero C, Lopez-Lazaro M. A review on the dietary flavonoid kaempferol. Mini-Rev Med Chem. 2011;11:298-344.
35. Yasukawa K, Takido M, Takeuchi M, Sato Y, Nitta K, Nakagawa S. Inhibitory effects of flavonol glycosides on 12-O-tetradecanoylphorbol-13-acetate-induced tumor promotion. Chem Pharm Bull. 1990;38:774-6. (Pubitemid 20316816)
36. Davis JM, Murphy EA, McClellan JL, Carmichael MD, Gangemi JD. Quercetin reduces susceptibility to influenza infection following stressful exercise. Am J Physiol- Reg Integ Comp Physiol. 2008;295:R505-R509.
37. Wleklik M, Luczak MPW, Kobus M, Lammer-Zarawska E. Structural basis for antiviral activity of flavonoids-naturally occurring compounds. Acta Virol. 1988;32:522-5. (Pubitemid 19047069)
38. Chen C, Zhou J, Ji C. Quercetin: a potential drug to reverse multidrug resistance. Life Sci. 2010;87:333-8.
39. Gibellini L, Pinti M, Nasi M, Montagna JP, Debiasi S, Roat E, Bertoncelli L, Cooper EL, Cossarizza A. Quercetin and cancer chemoprevention. Evid Based Complement Alternat Med. 2011; 2011: Article ID 591356, 15 pages, doi:10.1093/ecam/neq053
40. Goldwasser J, Cohen PY, Lin W, Kitsberg D, Balaguer P, Polyak SJ, Chung RT, Yamush ML, Nahmias Y. Naringenin inhibits the assembly and long-term production of infectious hepatitis C virus particles through a PPAR-mediated mechanism. J Hepatol. 2011;55:963-9.
41. Zandi K, Teoh BT, Sam SS, Wong PF, Mustafa MR, AbuBakar S. In vitro antiviral activity of Fisetin, Rutin and Naringenin against Dengue virus type-2. J Med Plants Res. 2011;5:5534-9.
42. Guthrie N, Carroll KK. Inhibition of mammary cancer by citrus flavonoids. Adv Exp Med Biol. 1998;439:227-36. (Pubitemid 28429019)
43. Yadav VR, Prasad S, Sung B, Aggarwal BB. The role of chalcones in suppression of NF-+|B-mediated inflammation and cancer. Int Immunopharmacol. 2011;11:295-309.
44. Sabarinathan D, Mahalakshmi P, Vanisree AJ. Naringenin, a flavanone inhibits the proliferation of cerebrally implanted C6 glioma cells in rats. Chemico-Biological Interactions. 2011;189:26-36.
45. Qin L, Jin L, Lu L, Lu X, Zhang C, Zhang F, Liang W. Naringenin reduces lung metastasis in a breast cancer resection model. Protein Cell. 2011;2:507-16.
46. Akula SM, Hurley DJ, Wixon RL, Wang C, Chase CC. Effect of genistein on replication of bovine herpesvirus type 1. Am J Vet Res. 2002;63:1124-8. (Pubitemid 35276896)
47. Vela EM, Bowick GC, Herzog NK, Aronson JF. Exploring kinase inhibitors as therapies for human arenavirus infections. Future Virology. 2008;3:243-51. (Pubitemid 351715804)
48. Dixon RA, Ferreira D. Genistein. Phytochemistry. 2002;60:205-11. (Pubitemid 34947527)
49. Li QS, Li CY, Li ZL, Zhu HL. Genistein and its synthetic analogs as anticancer agents. Anticancer Agents Med Chem. 2011; Oct 25. [Epub ahead of print].
50. Efferth T. Molecular pharmacology and pharmacogenomics of artemisinin and its derivatives in cancer cells. Curr Drug Targets. 2006;7:407-21. (Pubitemid 43744832)
51. Efferth T. Mechanistic perspectives for 1,2,4-trioxanes in anti-cancer therapy. Drug Resist Updat. 2005;8:85-97. (Pubitemid 40797959)
52. Efferth T, Schwabe W. Award 2006: antiplasmodial and antitumor activity of artemisinin - from bench to bedside. Planta Med. 2007;73:299-309. (Pubitemid 46910410)